165 related articles for article (PubMed ID: 9669206)
1. Inhibition of leukotriene B4-induced increase in intracellular calcium ion level of human peripheral blood polymorphonuclear leukocytes by Y-24180, an antagonist of platelet-activating factor receptor.
Komatsu H; Amano M
Int J Immunopharmacol; 1997; 19(11-12):661-7. PubMed ID: 9669206
[TBL] [Abstract][Full Text] [Related]
2. Interactions between synthesis of platelet-activating factor and leukotriene B4 in isolated human polymorphonuclear leukocytes.
Moilanen E; Kirkkola AL; Kankaanranta H; Nieminen MM; Vapaatalo H
Inflammation; 1993 Dec; 17(6):705-14. PubMed ID: 8112829
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of activation of human peripheral blood eosinophils by Y-24180, an antagonist to platelet-activating factor receptor.
Komatsu H; Amano M; Yamaguchi S; Sugahara K
Life Sci; 1999; 65(13):PL171-6. PubMed ID: 10503965
[TBL] [Abstract][Full Text] [Related]
4. Effects of platelet activating factor receptor antagonists on intracellular platelet activating factor function in neutrophils.
Koike H; Imanishi N; Natsume Y; Morooka S
Eur J Pharmacol; 1994 Nov; 269(3):299-309. PubMed ID: 7895770
[TBL] [Abstract][Full Text] [Related]
5. Effect of Y-24180, a long-acting antagonist to platelet-activating factor (PAF), on PAF-induced reactions: a relationship between the partial structure of the compound and its duration of the action.
Kagoshima M; Tomomatsu N; Iwahisa Y; Yamaguchi S; Kawakami Y; Terasawa M
Pharmacology; 1997 May; 54(5):261-70. PubMed ID: 9380772
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological actions of Y-24180, a new specific antagonist of platelet activating factor (PAF): II. Interactions with PAF and benzodiazepine receptors.
Takehara S; Mikashima H; Muramoto Y; Terasawa M; Setoguchi M; Tahara T
Prostaglandins; 1990 Dec; 40(6):571-83. PubMed ID: 1965554
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of leukocyte adhesion to endothelial cells of human umbilical vein by Y-24180, an antagonist of platelet-activating factor.
Komatsu H; Nagasawa M; Okumoto T
Int J Immunopharmacol; 1993 Aug; 15(6):737-44. PubMed ID: 7691768
[TBL] [Abstract][Full Text] [Related]
8. Mediation by platelet-activating factor of 12-hydroxyeicosatetraenoic acid-induced cytosolic free calcium concentration elevation in neutrophils.
Shibata K; Yoshino H; Mizuno N; Shinohara H; Morita K; Kitayama S; Kurihara H; Dohi T
Prostaglandins Other Lipid Mediat; 2000 Oct; 62(4):385-94. PubMed ID: 11060901
[TBL] [Abstract][Full Text] [Related]
9. Partial agonist effect of the platelet-activating factor receptor antagonists, WEB 2086 and WEB 2170, in the rat perfused heart.
Hu W; McNicholl IK; Choy PC; Man RY
Br J Pharmacol; 1993 Oct; 110(2):645-50. PubMed ID: 8242237
[TBL] [Abstract][Full Text] [Related]
10. Changes of cytosolic calcium ion concentrations in human endothelial cells in response to thrombin, platelet-activating factor, and leukotriene B4.
Lerner R
J Lab Clin Med; 1994 Nov; 124(5):723-9. PubMed ID: 7964131
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of the PAF receptor antagonist UK-74,505 on neutrophil and eosinophil accumulation in guinea-pig skin.
Sanz MJ; Weg VB; Walsh DT; Williams TJ; Nourshargh S
Br J Pharmacol; 1994 Oct; 113(2):513-21. PubMed ID: 7834203
[TBL] [Abstract][Full Text] [Related]
12. 13-HODE inhibits the intracellular calcium increase of activated human polymorphonuclear cells.
van de Velde MJ; Engels F; Henricks PA; Nijkamp FP
J Leukoc Biol; 1994 Aug; 56(2):200-2. PubMed ID: 8071595
[TBL] [Abstract][Full Text] [Related]
13. Impaired surface expression of PAF receptors on human neutrophils is dependent upon cell activation.
Zhou W; Javors MA; Olson MS
Arch Biochem Biophys; 1994 Feb; 308(2):439-45. PubMed ID: 8109973
[TBL] [Abstract][Full Text] [Related]
14. Mesenteric microvascular inflammatory responses to systemic hypoxia are mediated by PAF and LTB4.
Casillan AJ; Gonzalez NC; Johnson JS; Steiner DR; Wood JG
J Appl Physiol (1985); 2003 Jun; 94(6):2313-22. PubMed ID: 12598480
[TBL] [Abstract][Full Text] [Related]
15. Chemotactic peptide down-regulation of calcium mobilization induced by platelet-activating factor and by leukotriene B4 in human neutrophils is uncovered by protein phosphatase inhibitors.
Montero M; Garcia-Sancho J; Alverez J
Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):559-66. PubMed ID: 7980418
[TBL] [Abstract][Full Text] [Related]
16. The platelet activating factor receptor antagonist, RP 59227, blocks platelet activating factor receptors mediating liberation of reactive oxygen species in guinea pig macrophages and human polymorphonuclear leukocytes.
Floch A; Tahraoui L; Sedivy P; Cavero I
J Pharmacol Exp Ther; 1991 Aug; 258(2):567-75. PubMed ID: 1650834
[TBL] [Abstract][Full Text] [Related]
17. PAF-mediated platelet adhesion to endothelial cells induced by FMLP-stimulated leukocytes.
Hirafuji M; Shinoda H
J Lipid Mediat; 1991 Nov; 4(3):347-51. PubMed ID: 1662550
[TBL] [Abstract][Full Text] [Related]
18. Platelet-activating factor induced calcium mobilization and phosphoinositide metabolism in cultured bovine cerebral microvascular endothelial cells.
Lin AY; Rui YC
Biochim Biophys Acta; 1994 Nov; 1224(2):323-8. PubMed ID: 7981248
[TBL] [Abstract][Full Text] [Related]
19. Enhancement by staurosporine of platelet-activating factor formation in N-formyl peptide-challenged human neutrophils is mediated by intracellular platelet-activating factor binding sites.
Müller S; Nigam S
Biochem Biophys Res Commun; 1992 Dec; 189(2):771-6. PubMed ID: 1335246
[TBL] [Abstract][Full Text] [Related]
20. Effect of a platelet-activating factor antagonist, WEB 2086, on inhibition of active oxygen generation in human polymorphonuclear leukocytes.
Suzuki S; Sugai K; Sato H; Arakawa M
Pharmacology; 1994 Feb; 48(2):111-8. PubMed ID: 8134402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
